Various methods for the synthesis of copper nanoparticles employing chemical, physical and biological techniques considering bottom-up and top-down methods synthesis have been studied. The properties of copper nanoparticles depend largely on their synthesis procedures. The results from various investigations performed by di®erent scientists using these methods have been summarized. The applications, characterization techniques, advantages and disadvantages of each synthesis method are also the point of discussion. A detailed study of the results reveals that chemical reduction methods are most suitable for the synthesis of copper nanoparticles. Chemical reduction of copper salts using ascorbic acid (Vitamin C) is a new and green approach in which ascorbic acid is used both as the reduction and capping agent. This approach is the most e®ective and is also economical. Wide applications have been reported in various¯elds, including heat transfer, catalyst production, electronics and medicine at a commercial scale. This process is nontoxic, environment-friendly and economical. The applications, characterization techniques, advantages and disadvantages of each synthesis method have been presented.
Chemical Reduction technique was employed to prepared highly stable and dispersed Copper nanoparticles using L-Ascorbic Acid (Vitamin C) as reducing as well as capping agent. In this technique, cupric chloride was used as precursor. The effects of different molar ratios of L-Ascorbic Acid on the concentration and size of copper nanoparticles were studied. The Copper nanoparticles were characterized by X-Ray Diffraction, Atomic Absorption Spectrometry, and Fourier Transform Infrared Spectrometry. The results show that with the increase in the molar ratio of L-ascorbic acid the concentration of Copper nanoparticles were also increased. The average particles size of copper nanoparticle was found in the range of 50-60 nm. The product was kept in ambient conditions for three month but no sedimentation or separation was observed. The use of ascorbic acid makes the process a non-toxic, cost effective and environmental friendly green method.
The oral delivery of cancer chemotherapeutic drugs is challenging due to low bioavailability, gastrointestinal side effects, first-pass metabolism and P-glycoprotein efflux pumps. Thus, chemotherapeutic drugs, including Docetaxel, are administered via an intravenous route, which poses many disadvantages of its own. Recent advances in pharmaceutical research have focused on designing new and efficient drug delivery systems for site-specific targeting, thus leading to improved bioavailability and pharmacokinetics. A decent number of studies have been reported for the safe and effective oral delivery of Docetaxel. These nanocarriers, including liposomes, polymeric nanoparticles, metallic nanoparticles, hybrid nanoparticles, dendrimers and so on, have shown promising results in research papers and clinical trials. The present article comprehensively reviews the research efforts made so far in designing various advancements in the oral delivery of Docetaxel. Different strategies to improve oral bioavailability, prevent first-pass metabolism and inhibition of efflux pumping leading to improved pharmacokinetics and anticancer activity are discussed. The final portion of this review article presents key issues such as safety of nanomaterials, regulatory approval and future trends in nanomedicine research.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.